Header Logo

Connection

VIVEK SUBBIAH to Recombinant Proteins

Back to Details
This is a "connection" page, showing publications VIVEK SUBBIAH has written about Recombinant Proteins.
VIVEK SUBBIAH
Connection Strength
0.288
Recombinant Proteins
  1. Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist. Mol Cancer Ther. 2012 Nov; 11(11):2541-6.
    View in: PubMed
    Score: 0.288
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.